期刊
FRONTIERS IN ONCOLOGY
卷 10, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2020.563938
关键词
dual-targeting; biomimetic nanoparticles; NGR; (WSW)-W-D; blood– brain barrier; blood– brain tumor barrier; euphorbia factor L1; glioma
类别
资金
- Beijing Municipal Natural Science Foundation [7182097, 7172162]
- National Natural Science Foundation of China [81673597, 81874305]
- National Key Research and Development Program of China [2018YFE0197900, 2018YFC0115604]
Penetration of the blood-brain barrier (BBB) and the blood-brain tumor barrier (BBTB) remains a significant challenge for the delivery of drugs in the treatment of glioma. Therefore, the development of targeted preparations with the ability to penetrate the BBB and BBTB, and target gliomas, is an important approach if we are to improve the efficacy of glioma treatment. In the current study, an active targeting preparation based on PLGA nanoparticles coated with erythrocyte membranes (RBCNPs) and dual-modified with (WSW)-W-D and NGR peptide ligands ((WSW)-W-D/NGR-RBCNPs). Euphorbia factor L1 (EFL1) extracted from euphorbiae semen was used as the model drug. The final nanoparticles were characterized by in vivo and in vitro tests. In vitro results showed that EFL1-loaded (WSW)-W-D/NGR-RBCNPs were taken up by cells and had the ability to penetrate the BBB and BBTB and produce cytotoxic effects. Furthermore, in vivo studies in mice showed that when injected intravenously, these specialized NPs could enter the brain, target tumor tissue, and significantly extend life span. The results showed that dual-targeting EFL1-loaded (WSW)-W-D/NGR-RBCNPs have significant potential as a nanotherapeutic tool for the treatment of brain glioma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据